Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Takuyuki Matsumoto"'
Autor:
Takeshi Yamashita, Joji Hagii, Yoshiyuki Morishima, Takaaki Akasaka, Takuyuki Matsumoto, Tetsuya Kimura
Publikováno v:
Thrombosis Journal, Vol 17, Iss 1, Pp 1-14 (2019)
Abstract Background This study involved a sensory evaluation of edoxaban orally disintegrating (OD) tablets in patients with nonvalvular atrial fibrillation who had been receiving the existing edoxaban film-coated tablets before the study. Methods Ed
Externí odkaz:
https://doaj.org/article/bf2b22578a354c5c84eaa99236ea63c2
Autor:
Akiko Hayakawa, Hirokazu Tanabe, Kazuhiro Uchino, Takeshi Yamashita, Toru Sekine, Takuyuki Matsumoto, Masato Nakamura, Tomoko Iizuka, Chie Hasegawa, Seiji Kogure, Atsushi Takita
Publikováno v:
Journal of Cardiology. 77:186-194
Background Current guidelines recommend early termination of triple therapy and the use of direct oral anticoagulants (DOAC) for non-valvular atrial fibrillation (NVAF) patients who undergo percutaneous coronary intervention (PCI), due to safety conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96713ae66ebd2a8c3a73168142a5d0c0
https://doi.org/10.1016/j.jjcc.2020.08.008
https://doi.org/10.1016/j.jjcc.2020.08.008
Autor:
Takeshi Kitai, Takuyuki Matsumoto, Misa Takegami, Yutaka Furukawa, Chisato Izumi, Makoto Miyake, Masashi Amano, Kumiko Sugio, Kunihiro Nishimura, Yuki Obayashi, Tetsuya Kimura
Publikováno v:
Journal of Cardiology. 76:44-50
Background The incidence of cardiovascular diseases, including valvular heart disease and atrial fibrillation (AF), is rising as the elderly population increases. For patients with AF and bioprosthetic valves, current treatment guidelines for antithr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::302b594c0f760c11167ba0e0db9bc81f
https://doi.org/10.1016/j.jjcc.2020.02.006
https://doi.org/10.1016/j.jjcc.2020.02.006
Autor:
Hideki Origasa, Tetsuya Kimura, Yasushi Mukai, Keita Yamaguchi, Takuyuki Matsumoto, Kyu-Rable Investigators, Naohiko Takahashi, Ken Okumura
Publikováno v:
Circulation Journal. 83:2017-2024
Background The KYU-RABLE study, a prospective, multicenter, single-arm interventional study, evaluated the efficacy and safety of uninterrupted oral edoxaban in patients undergoing catheter ablation (CA) for atrial fibrillation (AF).Methods and Resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9238f2874b5988df20f9c6881efd7808
https://doi.org/10.1253/circj.cj-19-0535
https://doi.org/10.1253/circj.cj-19-0535
Autor:
Shigeru Fujimoto, Hiroyuki Daida, Jumpei Kaburagi, Kazumi Kimura, Tetsuya Kimura, Wataru Shimizu, Yu-ki Iwasaki, Yuki Sakamoto, Teppei Yamamoto, Toshiaki Otsuka, Takuya Kanamaru, Takuyuki Matsumoto, Yasuyuki Iguchi, Kazunori Toyoda, Susumu Miyamoto, Kazuo Kitagawa, Ken Okumura, Nobuhisa Hagiwara, Kengo Kusano, Yasuhiro Nishiyama
Publikováno v:
Journal of cardiology. 74(6)
Background Catheter ablation (CA) has been reported to reduce risk of stroke in patients with nonvalvular atrial fibrillation (NVAF) in retrospective studies. However, the risks and benefits of CA have not been well elucidated in patients with NVAF a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836416cb38c2b5d0514ee81ae5a039fa
https://pubmed.ncbi.nlm.nih.gov/31337525
https://pubmed.ncbi.nlm.nih.gov/31337525
Autor:
Takaaki Akasaka, Joji Hagii, Takuyuki Matsumoto, Tetsuya Kimura, Yoshiyuki Morishima, Takeshi Yamashita
Publikováno v:
Thrombosis Journal, Vol 17, Iss 1, Pp 1-14 (2019)
Thrombosis Journal
Thrombosis Journal
Background This study involved a sensory evaluation of edoxaban orally disintegrating (OD) tablets in patients with nonvalvular atrial fibrillation who had been receiving the existing edoxaban film-coated tablets before the study. Methods Edoxaban OD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::988a9a87566d378e8bab20ea81fc8d3b
https://doi.org/10.1186/s12959-019-0192-x
https://doi.org/10.1186/s12959-019-0192-x
Autor:
Takahiro Ushida, Hiroshi Sakoda, Takuyuki Matsumoto, Daiju Matsui, Teruyoshi Inoue, Takao Kurusu, Hiroshi Takatsuna, Atsushi Takita, Mizuka Yokoyama, Kaoru Okuizumi
Background: Information on prescriptions of oral analgesics for the treatment of pain is beneficial. However, there have been few reports on the prescription status of oral analgesics from a nation-wide, large-scale prescription database in Japan. Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64735206691154e6532bd74c4bade774
Autor:
Yamashita, Takeshi, Hagii, Joji, Morishima, Yoshiyuki, Akasaka, Takaaki, Takuyuki Matsumoto, Kimura, Tetsuya
Table S1. Results of the sensory evaluation questionnaire about edoxaban OD tablets shown by dose level (30â mg/60â mg) and with/without water. (DOCX 24 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24487718c41fef8e67d79b6a3112c20d
Autor:
Kengo Saito, Takuyuki Matsumoto, Yoshikazu Fukuchi, Daiju Matsui, Kaoru Okuizumi, Teruyoshi Kamata
Publikováno v:
Expert opinion on pharmacotherapy. 19(5)
Responder analyses assessing clinical worsening have attempted to clarify clinically meaningful drug efficacy enhancements in patients with Alzheimer's disease (AD).This was a meta-analysis of two multicenter, randomized, double-blind, parallel-group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab1043c4c9db8f5bcc81e92372123fd
https://pubmed.ncbi.nlm.nih.gov/29448852
https://pubmed.ncbi.nlm.nih.gov/29448852
Autor:
Takuyuki Matsumoto, Tomoko Iizuka, Natsuko Zenimura, Masahiro Komiya, Katsutoshi Hiramatsu, Yasuhiro Nishikawa, Yoshihiro Mori
Publikováno v:
Drugs in R&D. 11:171-190
Background: In Japan, when pharmaceutical companies launch a new drug, they are obligated to conduct a post-marketing survey to evaluate the safety and efficacy of the drug in accordance with Good Post-Marketing Surveillance Practice under Article 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15a3b9192183bb8f9e38f1a8737ccdb8
https://doi.org/10.2165/11592450-000000000-00000
https://doi.org/10.2165/11592450-000000000-00000